Adverse event reporting and harms {22}
ADVERSE EVENTS
The investigator must immediately (within 24 h) report to the sponsor’s unique entry point serious adverse events (SAEs), AEs of special interest and non-SAEs that are relevant to the reported SAE or AE of special interest, using the Boehringer Ingelheim SAE form. The same timeline will apply if follow-up information becomes available.